EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Impact of Paxlovid on Tacrolimus Concentration in Kidney Transplant Patients: A Retrospective Observational Study

Wen-Jing Li, Yun Lu, Zi-Biao Zhong, Su-Yu Gao, Cheng-Biao Xue, Wen Hu, Zhong-Zhong Liu, Xuan-Xuan Wang, Zhi-Gao Deng, Shao-Jun Ye, Hong Cheng

Transplantation Proceedings · 2024

DOI: 10.1016/j.transproceed.2024.10.008 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Transplantation Proceedings, 2024. Verfasst von Wen-Jing Li und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Zhongnan Hospital of Wuhan University, Wuhan, China. Hauptthemen laut MEDLINE: Kidney Transplantation, Tacrolimus, Immunosuppressive Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Health Commission of Hubei Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kidney transplant recipients, reliant on lifelong immunosuppressive therapy, face potential drug interactions with emerging treatments such as paxlovid. This study aims to provide guidance for safe administration by examining the impact of paxlovid on tacrolimus levels in kidney transplant recipients. Seven kidney transplant patients who received paxlovid between December 2022 and August 2023 were included for retrospective analysis. Tacrolimus concentration changes were investigated both during and after the administration of paxlovid. Genetic testing for CYP3A5 polymorphisms assessed individual responses. The patient's treatment process was divided into four phases according to the paxlovid administration and the Tacrolimus trough level. The variation of tacrolimus valley concentration, concentration-to-dose ratios (C/D), and creatinine values in different periods were subsequently described and analyzed. The results indicate that tacrolimus levels increased significantly after receiving paxlovid, peaking on day two with a median trough level of 21.8 ng/mL. Prior to the administration of paxlovid, the median C/D value was 6.8 times higher (903.1 to 132.5). Once the paxlovid was stopped, the C/D value and trough level progressively returned to their preadministration levels. Importantly, no graft rejections, adverse events, or neurotoxicity were noted. The levels of creatinine remained stable. During paxlovid treatment, patients adhered to a modified tacrolimus regimen and progressively resumed baseline dosage. In summary, this is the first study to indicate a significant influence of paxlovid on tacrolimus levels in Chinese patients undergoing kidney transplantation. During paxlovid treatment, careful observation and tailored tacrolimus management are crucial to guarantee safe administration and circumvent negative consequences.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationTacrolimusImmunosuppressive AgentsHumansRetrospective StudiesMaleFemaleMiddle AgedAdultDrug InteractionsCytochrome P-450 CYP3AGraft Rejection

Substanzen

TacrolimusImmunosuppressive AgentsCytochrome P-450 CYP3ACYP3A5 protein, human

Autor:innen und Institutionen

  • Department of Pharmacy, Zhongnan Hospital of Wuhan University, Wuhan, China.
  • Zhongnan Hospital of Wuhan University, Institute of Hepatobiliary Diseases of Wuhan University, Transplant Center of Wuhan University, Hubei Key Laboratory of Medical Technology on Transplantation, Engineering Research…
  • Department of Pharmacy, Zhongnan Hospital of Wuhan University, Wuhan, China. Electronic address: chenghong@znhospital.cn.

Förderung

  • Health Commission of Hubei Province

Zitieren

APA

Li, W. J., Lu, Y., Zhong, Z. B., Gao, S. Y., Xue, C. B., Hu, W., Liu, Z. Z., Wang, X. X., Deng, Z. G., Ye, S. J., & Cheng, H. (2024). Impact of Paxlovid on Tacrolimus Concentration in Kidney Transplant Patients: A Retrospective Observational Study. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2024.10.008

Vancouver

Li WJ, Lu Y, Zhong ZB, Gao SY, Xue CB, Hu W, et al. Impact of Paxlovid on Tacrolimus Concentration in Kidney Transplant Patients: A Retrospective Observational Study. Transplantation Proceedings. 2024. doi:10.1016/j.transproceed.2024.10.008

BibTeX
@article{Li2024,
  author = {Li, Wen-Jing and Lu, Yun and Zhong, Zi-Biao and Gao, Su-Yu and Xue, Cheng-Biao and Hu, Wen and Liu, Zhong-Zhong and Wang, Xuan-Xuan and Deng, Zhi-Gao and Ye, Shao-Jun and Cheng, Hong},
  title = {Impact of Paxlovid on Tacrolimus Concentration in Kidney Transplant Patients: A Retrospective Observational Study},
  journal = {Transplantation Proceedings},
  year = {2024},
  doi = {10.1016/j.transproceed.2024.10.008}
}
Kostenlos starten →